Laser Photonics’ CleanTech Streamlines Biofilm Removal in Industrial Settings

ORLANDO, Fla.--(BUSINESS WIRE)-- Laser Photonics Corporation, a leading global industrial developer of CleanTech laser systems for laser cleaning and other material applications, highlights a key application for its CleanTech laser systems.

Wayne Tupuola, CEO of Laser Photonics, commented, “Our CleanTech laser cleaning system provides a highly effective and cost-efficient method of removing biofilms from a wide variety of materials and surfaces.”

Biofilms form in moist environments when microorganisms adhere to the surface of objects by excreting a slimy, glue-like substance. Biofilms can form on water treatment system components, food processing plant machinery, medical devices and boat hulls. CleanTech laser cleaning lets you quickly vaporize biofilms from nearly any surface with a non-contact, eco-friendly procedure that is operator-safe and easy to use.

For more information about the CleanTech line of roughing, conditioning, and finishing laser systems, please visit https://www.laserphotonics.com/spn or contact our sales department at [email protected].

CleanTech Laser Blasting Technology

The CleanTech Laser Blasting Technology manufactured by Laser Photonics is eco-friendly, cost-effective and time-efficient. Applications include rust removal, paint removal, surface preparation and more. This technology is an excellent alternative to traditional cleaning methods like sandblasting, dry ice blasting and other abrasive blasting techniques.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230919975886/en/

Media Contact:
David Thierer
Marketing Specialist
Laser Photonics Corporation
[email protected]

Source: Laser Photonics Corporation

You May Also Be Interested In

• Sky9 Capital Expands Into Europe With the Opening of a New Office in Paris
• Ethereum and Arbitrum Price Prediction: ARB Rebounds as Remittix Offers a Completely Different Growth Story
• Sebela Pharmaceuticals to Present Positive Phase 3 Tegoprazan Data in Non-Erosive Reflux Disease (NERD) at the American College of Gastroenterology (ACG) 2026 Meeting